{"gene":"CREM","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":1991,"finding":"CREM encodes multiple isoforms (repressors) generated by alternative cell-specific splicing that use two alternative DNA-binding domains; CREM proteins bind CRE sequences with the same efficiency and specificity as CREB but act as down-regulators (antagonists) of cAMP-induced transcription.","method":"PCR, RNase protection, cell-specific splicing analysis, transcription assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — original characterization using multiple orthogonal methods (PCR, RNase protection, in vitro binding, transcription assays); replicated extensively by subsequent independent studies","pmids":["1847666"],"is_preprint":false},{"year":1992,"finding":"A novel CREM isoform (CREM tau) expressed in adult testis contains two glutamine-rich activation domains inserted by alternative splicing and functions as a transcriptional activator rather than a repressor; during spermatogenesis, CREM undergoes a developmental switch from antagonist isoforms in premeiotic cells to the CREM tau activator from pachytene spermatocytes onwards.","method":"Alternative splicing analysis, functional transcription assays, developmental expression analysis in testis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (molecular cloning, transcription assays, developmental stage analysis); independently replicated by multiple labs","pmids":["1370576"],"is_preprint":false},{"year":1992,"finding":"CREM antagonists repress c-Jun-mediated transcriptional activation not by heterodimerizing with Fos/Jun proteins, but by directly binding to TRE (AP-1) sequences and competing with c-Jun for these sites; removal of the phosphorylation domain from CREM does not affect this down-regulatory function.","method":"Transcription assays, DNA-binding competition, dimerization analysis, domain deletion mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — mechanistic dissection using domain deletion mutants and direct binding competition assays in a single rigorous study with multiple orthogonal approaches","pmids":["1429597"],"is_preprint":false},{"year":1993,"finding":"CREM is uniquely inducible within the CRE-binding family upon cAMP pathway activation; an alternative intronic promoter drives expression of a novel repressor isoform ICER (inducible cAMP early repressor); ICER binds to four CREs in its own intronic promoter and represses its own transcription, establishing a negative autoregulatory feedback loop.","method":"Alternative promoter cloning, kinetic induction analysis, protein synthesis inhibition, transfection reporter assays, ICER binding assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (promoter characterization, reporter assays, binding assays, cycloheximide experiments); replicated by multiple independent studies","pmids":["8252624"],"is_preprint":false},{"year":1993,"finding":"CREM tau activator is phosphorylated at serine-117 by endogenous germ cell protein kinase A; this phosphorylation enhances transcriptional activation. Casein kinase I and II cooperatively phosphorylate CREM tau on multiple residues to enhance DNA binding. Multiple signal transduction pathways (cAMP, TPA, Ca2+ ionophore) converge on phosphorylation of Ser-117.","method":"In vitro and in vivo phosphorylation assays, site-directed mutagenesis, DNA-binding assays, transactivation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro kinase assays with multiple kinases, in vivo phosphorylation, and functional transcription assays; multiple orthogonal methods in single study","pmids":["8404858"],"is_preprint":false},{"year":1993,"finding":"The CREM gene has a modular exon structure; isoforms are generated by exon shuffling producing proteins with various combinations of functional domains. CREM isoforms heterodimerize in vivo with each other and with CREB; the two alternative DNA-binding domains show distinct binding efficiencies (CREM alpha/CREB heterodimers bind consensus CRE more strongly than CREM beta/CREB heterodimers). The phosphorylation domain and a single glutamine-rich domain are sufficient for activation. A minimal CREM repressor containing only the bZip motif efficiently antagonizes cAMP-induced transcription. A Ser phosphoacceptor site mutation (CREM beta S68) increases repressor function.","method":"Exon structure determination, in vivo heterodimerization, in vitro DNA binding assays, domain deletion/mutation analysis, transcription assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — comprehensive domain analysis with multiple deletion and point mutants, in vivo and in vitro assays, multiple orthogonal methods","pmids":["8458330"],"is_preprint":false},{"year":1993,"finding":"FSH is responsible for directing the CREM developmental switch from antagonist to activator (CREM tau) in testis; FSH regulates CREM expression by alternative polyadenylation, which results in dramatic enhancement of transcript stability. Hypophysectomy abolishes CREM tau expression, and FSH administration restores it.","method":"Hypophysectomy, hormone administration, polyadenylation analysis, transcript stability measurement","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo hormonal manipulation with multiple controls, molecular mechanism (alternative polyadenylation/stability) demonstrated; replicated in independent systems","pmids":["7681549"],"is_preprint":false},{"year":1993,"finding":"The KID (kinase-inducible domain) of CREB/CREM-alpha acts as a conditional activator that can confer cAMP-inducible transcriptional activation even to activation domains on a separate polypeptide bound at an adjacent promoter site, suggesting KID functions as a trans-acting conditional activator module.","method":"Domain fusion/swap transcription assays, artificial tethering experiments","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transcription assays with domain fusions; single lab, primarily focused on CREB mechanism with CREM-alpha as comparator","pmids":["8102791"],"is_preprint":false},{"year":1993,"finding":"CREM tau activator is phosphorylated by p34cdc2 on multiple serine and threonine residues in vitro and in vivo; p34cdc2-mediated phosphorylation does not affect CREM tau DNA binding but strongly reduces its trans-activation potential (as shown by coexpression of constitutively active p34cdc2 mutant).","method":"In vitro and in vivo phosphorylation assays, constitutively active p34cdc2 coexpression, transactivation assays, DNA binding assays","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstituted phosphorylation plus in vivo validation with active mutant and functional readout; single lab but multiple orthogonal methods","pmids":["8114763"],"is_preprint":false},{"year":1993,"finding":"CREM tau binds to CREs in the promoters of several postmeiotic germ cell-specific genes (including RT7); CREM tau activates the RT7 promoter in transfection assays; CREM-specific antibodies block in vitro transcription from the RT7 promoter using seminiferous tubule nuclear extracts, directly implicating CREM tau in activating postmeiotic gene expression.","method":"EMSA, transient transfection reporter assays, in vitro transcription with antibody blockade, nuclear extracts from seminiferous tubules","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro transcription assay with antibody inhibition plus transfection assays; multiple orthogonal methods in single study","pmids":["8114765"],"is_preprint":false},{"year":1993,"finding":"Rhythmic adrenergic signals from the circadian clock drive ICER expression in the pineal gland via the cAMP signal transduction pathway; ICER levels show striking circadian fluctuation (peak at night), correlating inversely with melatonin synthesis.","method":"In vivo circadian expression analysis, adrenergic stimulation, cAMP pathway activation","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo physiological system with pharmacological pathway manipulation; independently confirmed by multiple subsequent studies","pmids":["8397338"],"is_preprint":false},{"year":1994,"finding":"An alternatively spliced CREM isoform (CREM delta C-G) lacking the PKA phosphorylation domain and glutamine-rich activation domains retains the bZip DNA-binding domain, competitively inhibits CREB/CREM binding to CREs, represses CRE-driven reporter transcription, and is expressed in elongated spermatids in rat testis.","method":"RT-PCR, DNA binding competition, reporter gene repression assays, immunostaining of testis sections","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple methods (molecular, cellular, tissue); competitive binding and functional repression demonstrated","pmids":["7809053"],"is_preprint":false},{"year":1994,"finding":"CREM alpha can contribute to PKA-mediated gene activation when selectively heterodimerized with CREB (using engineered leucine zipper specificity), and this transcriptional activity depends on the ability of the complexes to be phosphorylated by PKA; non-phosphorylated CREB.CREM alpha heterodimers are non-functional.","method":"Engineered leucine zipper dimerization, in vivo transcription assays, PKA phosphorylation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — engineered dimerization specificity with functional readout; mechanistic dissection of heterodimer activity vs. phosphorylation state","pmids":["7961842"],"is_preprint":false},{"year":1994,"finding":"CREM and CREB proteins induce bending in DNA sequences flanking the CRE recognition site; phosphorylation of CREM or CREB enhances the angle of DNA bending induced by these proteins, while not affecting binding affinity differences between the two alternative DNA-binding domains of CREM.","method":"Permutated binding site gel retardation assay (circular permutation), bacterially expressed proteins","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with purified protein but single lab, single method","pmids":["8290258"],"is_preprint":false},{"year":1996,"finding":"Homozygous CREM-mutant male mice (generated by homologous recombination) are sterile; spermatogenesis arrests at the first step of spermiogenesis with complete absence of late spermatids, a 10-fold increase in apoptotic germ cells, and lack of postmeiotic cell-specific gene expression. Female mice are fertile, confirming a male germ cell-specific essential function.","method":"Homologous recombination knockout, histology, TUNEL/apoptosis assays, gene expression analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent knockout studies published simultaneously with comprehensive phenotypic and molecular characterization","pmids":["8600390","8600391"],"is_preprint":false},{"year":1996,"finding":"CREM-deficient mice show dramatically elevated serotonin N-acetyltransferase (NAT) expression in the pineal gland; the NAT promoter contains an ICER binding site; ICER powerfully represses NAT transcription in transfection assays; thus CREM/ICER acts as a central regulator of circadian melatonin synthesis.","method":"CREM knockout mice, promoter characterization, EMSA, transfection reporter assays","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function genetics combined with promoter binding and functional reporter assays; multiple orthogonal methods","pmids":["8943074"],"is_preprint":false},{"year":1996,"finding":"The transcriptional response of the CREM gene to adrenergic stimulation is determined by the memory of past photoperiods (night length); differential responsiveness is controlled by the changing balance between positive (CREB) and negative (ICER) transcriptional regulators occupying the ICER promoter.","method":"Photoperiod manipulation in vivo, adrenergic stimulation, CREM/ICER expression quantification, promoter occupancy analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo physiological system with mechanistic promoter occupancy data; single lab but multiple conditions and orthogonal measurements","pmids":["8609995"],"is_preprint":false},{"year":1998,"finding":"CREM gene expression is robustly induced during liver regeneration after partial hepatectomy; CREM-deficient mice show significantly reduced hepatocyte proliferation (reduced DNA synthesis, fewer mitoses, delayed S-phase entry, deregulated cyclin/cdc2 expression), demonstrating CREM is required for normal timing of the hepatocyte cell cycle after partial hepatectomy.","method":"Partial hepatectomy in CREM knockout vs. wild-type mice, BrdU incorporation, histomorphometry, gene expression analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with defined proliferative phenotype and molecular characterization; single lab but multiple orthogonal readouts","pmids":["9851970"],"is_preprint":false},{"year":1999,"finding":"ACT (activator of CREM in testis), a LIM-only protein, specifically associates with CREM in male germ cells (isolated by yeast two-hybrid, confirmed by co-association); ACT has intrinsic transcriptional activation function and strongly stimulates CREM transcriptional activity independent of Ser-117 phosphorylation and CBP interaction, establishing a phosphorylation-independent route for CREM activation.","method":"Yeast two-hybrid screen, co-association assays, transcriptional activation assays in yeast and mammalian cells, phosphorylation-independent mutant analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid discovery with in vivo functional validation in multiple cell systems; mechanism confirmed by phosphorylation-site mutants; replicated by multiple subsequent studies","pmids":["10086359"],"is_preprint":false},{"year":2000,"finding":"A family of FHL (four-and-a-half-LIM-domain) proteins share structural organization with ACT and provide CBP-independent transcriptional activation to both CREB and CREM in tissue-specific and developmentally regulated manner; specific ACT LIM domain arrangements are essential for both transactivation and interaction with CREM.","method":"Yeast and mammalian cell transcription assays, deletion analysis, tissue expression profiling","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transcription assays with domain deletions in multiple cell systems; single lab","pmids":["11046156"],"is_preprint":false},{"year":2002,"finding":"ACT selectively associates with testis-specific kinesin KIF17b; the ACT-KIF17b interaction is restricted to specific stages of spermatogenesis and directly determines the intracellular localization of ACT; KIF17b can be actively exported from the nucleus through the CRM1 receptor (leptomycin B-sensitive), thereby controlling CREM-dependent transcription in male germ cells through regulation of coactivator localization.","method":"Co-immunoprecipitation, subcellular localization (immunofluorescence), leptomycin B treatment, stage-specific expression analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, live-cell localization with pharmacological perturbation, and stage-specific analysis; single lab but multiple orthogonal methods","pmids":["12493914"],"is_preprint":false},{"year":2002,"finding":"CREM-null mice lack abundant germ cell-specific CYP51 mRNA transcripts in testis (while somatic CYP51 remains unaffected); CREMtau binds to a conserved CRE2 element in the CYP51 promoter in germ cell nuclear extracts, whereas SREBP-1 (the somatic regulator) does not bind in germ cells; thus CREMtau-dependent regulation of CYP51 is the dominant pathway in haploid germ cells, replacing the SREBP-dependent cholesterogenic regulation.","method":"CREM knockout analysis, EMSA with germ cell nuclear extracts, promoter reporter assays","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo genetic loss-of-function combined with biochemical promoter-binding analysis demonstrating cell-type-specific regulatory mechanism","pmids":["10551787"],"is_preprint":false},{"year":2002,"finding":"CREM is required for postmeiotic transcription of ACE testicular isozyme (ACET): ACET mRNA is absent from testes of CREM-null mice while pulmonary ACE remains unaffected; a CRE element 5' of the ACET transcription start site is absolutely essential for testicular expression (shown by transgenic reporter).","method":"CREM knockout mice, transgenic reporter analysis, CRE mutation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function combined with transgenic CRE mutation establishing direct requirement for CREM at a specific promoter element","pmids":["9545342"],"is_preprint":false},{"year":2002,"finding":"CREM deficiency results in impaired cardiac contraction and relaxation, selective down-regulation of beta1-adrenergic receptors, and decreased ventricular SERCA (Ca2+-ATPase) expression; CREM-null mice show decreased responsiveness to beta-adrenergic stimulation, establishing CREM as a key regulator of cardiac gene expression required for normal contractile performance.","method":"CREM knockout mice, left ventricular hemodynamic assessment, beta-adrenergic stimulation, Western blot, gene expression analysis","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with multiple molecular and functional cardiac phenotype readouts; single lab","pmids":["12475904"],"is_preprint":false},{"year":2003,"finding":"CREM-null mice display markedly depressed cardiac force-frequency relationship (contractile augmentation and relaxation at faster rates); this is associated with reduced total and serine-phosphorylated phospholamban protein and increased protein phosphatase-1 (PP1) activity in CREM-/- hearts, without changes in SERCA or phospholamban gene expression or beta-adrenergic signaling, demonstrating novel CREM-dependent regulation of PP1 and PLB post-translational modification.","method":"CREM knockout mice, in vivo pressure-volume loops, frequency-dependent protocols, Western blot, PP1 activity assay","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with mechanistic protein-level analysis; multiple orthogonal readouts; single lab","pmids":["12554693"],"is_preprint":false},{"year":2005,"finding":"KIF17b transport of ACT is microtubule-independent and motor domain-independent; protein kinase A phosphorylates KIF17b, and this phosphorylation determines KIF17b's subcellular localization, thereby controlling CREM-mediated transcription in male germ cells through regulation of ACT nuclear availability.","method":"Domain deletion mutants, microtubule depolymerization assays, in vitro phosphorylation by PKA, subcellular fractionation/localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro phosphorylation combined with domain deletion and subcellular localization experiments; mechanistic pathway clearly established","pmids":["16002395"],"is_preprint":false},{"year":2005,"finding":"CaMKIV is increased in the nucleus of SLE T cells and is responsible for increased CREM expression and enhanced CREM binding to the IL-2 promoter (-180 CRE site), leading to decreased IL-2 production; expression of a dominant-inactive CaMKIV abolishes SLE-serum-induced CREM upregulation; anti-TCR/CD3 autoantibodies in SLE IgG are responsible for CaMKIV activation.","method":"Dominant-negative CaMKIV overexpression, CREM promoter binding assays (EMSA/ChIP), IL-2 promoter reporter assays, SLE patient T cells","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — dominant-negative genetic approach combined with binding and reporter assays; establishes CaMKIV→CREM→IL-2 pathway in patient cells","pmids":["15841182"],"is_preprint":false},{"year":2005,"finding":"The splicing factor SRp40 mediates the switch in CREM alternative splicing in human myometrial cells from CREMtau2alpha (activator) to CREMalpha (repressor) during pregnancy; SRp40 acts through multiple ESE (exonic splicing enhancer) motifs in the alternatively spliced CREM exons.","method":"Transient transfection of splicing factors, in vitro splicing assays, EMSA with SRp40, ESE mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro splicing reconstitution and in vivo functional assays with ESE mutations; single lab but multiple orthogonal methods","pmids":["16103121"],"is_preprint":false},{"year":2006,"finding":"CREMtau and Tisp40 (a bZip transcription factor) form a heterodimer that binds CRE motifs (but not UPRE); Tisp40 dramatically enhances CREM binding to CRE; the Tisp40DeltaTM-CREMtau heterodimer recruits histone chaperone HIRA to CRE sites; CREM regulates Tisp40alpha transcription, and both proteins co-occupy the Tisp40 promoter in vivo (ChIP).","method":"Co-immunoprecipitation, EMSA, ChIP, reporter assays, in vivo binding","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal interactions demonstrated by multiple methods (Co-IP, EMSA, ChIP); functional consequence (HIRA recruitment) characterized","pmids":["16595651"],"is_preprint":false},{"year":2011,"finding":"CREMα physically binds to a CRE site at -111/-104 within the proximal human IL17A promoter and increases its transcriptional activity; CREMα binding correlates with epigenetic changes (H3K27 hypomethylation, H3K18 hyperacetylation, CpG hypomethylation) at the IL17A locus in activated T cells and SLE T cells; decreased HDAC1 and DNMT3a recruitment to this CRE site accounts for the epigenetic alterations.","method":"ChIP, reporter assays, DNA methylation analysis, histone modification analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-confirmed promoter binding, reporter assays with mutation, and epigenetic characterization; multiple orthogonal methods; single lab","pmids":["22025620"],"is_preprint":false},{"year":2011,"finding":"CREMα mediates silencing of the IL2 gene in SLE T lymphocytes through recruitment of HDAC1 leading to gene-wide H3K18 deacetylation and DNMT3a-mediated CpG-DNA hypermethylation at the IL2 gene locus.","method":"ChIP, bisulfite sequencing (CpG methylation), siRNA knockdown, reporter assays with methylated promoter","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-based epigenetic mechanism with multiple modifications measured; functional reporter validation; single lab","pmids":["21976679"],"is_preprint":false},{"year":2011,"finding":"A novel intronic CREM promoter (P2) upstream of exon 2 is regulated by AP-1 transcription factors; T cell activation via CD3/CD28 or PMA/ionomycin enhances P2 promoter activity; in SLE T cells, decreased c-Fos (an AP-1 component) impairs activation-induced CREM upregulation through P2; CREM trans-represses c-fos transcription in SLE T cells, establishing a CREM-AP-1 autoregulatory feedback loop.","method":"DNA binding studies (EMSA), ChIP, reporter assays, T cell stimulation experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — EMSA, ChIP, and reporter assays establishing AP-1-dependent promoter regulation and feedback mechanism; multiple orthogonal methods","pmids":["21757709"],"is_preprint":false},{"year":2013,"finding":"DAZAP1 promotes inclusion of CREM exon 4 in splicing reporter transcripts; DAZAP1 binds to regulatory regions in CREM intron 3 and regulates exon inclusion; DAZAP1-deficient mouse testes show aberrant CREM splicing, identifying DAZAP1 as a splicing regulator of CREM.","method":"Microarray exon usage analysis, minigene splicing reporters, RNA-binding assays, DAZAP1 knockout","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo splicing changes in knockout mice combined with minigene and binding studies; multiple orthogonal methods","pmids":["23965306"],"is_preprint":false},{"year":2014,"finding":"CaMK4 is required for Th17 cell differentiation; CaMK4 activates CREMα which in turn increases IL17A and IL17F transcription; CaMK4 also activates the AKT/mTOR pathway. Genetic or pharmacological inhibition of CaMK4 reduces IL-17 production through decreased CREMα activation; silencing CaMK4 in SLE and healthy T cells inhibits Th17 differentiation via reduction of IL17A and IL17F mRNA.","method":"CaMK4 knockout mice, pharmacological inhibition, Th17 differentiation assays, cytokine measurement, mRNA analysis, siRNA in human T cells","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (KO mice) and pharmacological inhibition with molecular readouts; validated in human SLE patient T cells; multiple independent approaches","pmids":["24667640"],"is_preprint":false},{"year":2016,"finding":"Transgenic cardiac expression of CREM repressor isoform CREM-IbΔC-X leads to arrhythmogenic alterations in ventricular cardiomyocytes including enhanced NCX-mediated Ca2+ transport, increased NCX1 protein, decreased Ito and KChIP2 subunit, action potential prolongation, early afterdepolarizations, and ventricular extrasystoles in vivo; CREM repressor expression suppresses CRE-dependent transcription to produce an arrhythmogenic remodeling substrate.","method":"Transgenic mouse model, patch clamp, calcium imaging, Western blot, RT-qPCR, telemetry ECG","journal":"Basic research in cardiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — transgenic gain-of-function with comprehensive electrophysiological, molecular, and in vivo functional analysis; multiple orthogonal methods","pmids":["26818679"],"is_preprint":false},{"year":2025,"finding":"CREM is induced in CAR-NK cells by both CAR activation and IL-15 signaling via the PKA-CREB signaling pathway downstream of ITAM/CAR signaling; CREM deletion enhances CAR-NK cell effector function in vitro and in vivo and increases resistance to tumor-induced immunosuppression; CREM exerts its regulatory functions through epigenetic reprogramming of CAR-NK cells.","method":"Transcriptomic analysis, CREM knockout, in vitro and in vivo functional assays, pharmacological PKA-CREB pathway inhibition, epigenetic profiling","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function combined with in vivo tumor models, pathway epistasis, and epigenetic characterization; multiple orthogonal methods in peer-reviewed Nature paper","pmids":["40468083"],"is_preprint":false}],"current_model":"CREM is a modular bZip transcription factor that generates multiple activator and repressor isoforms through alternative splicing, alternative promoter usage, and alternative polyadenylation; repressor isoforms compete with CREB for CRE binding while the activator isoform CREMτ is phosphorylated at Ser-117 by PKA (and regulated negatively by p34cdc2) or activated in a phosphorylation-independent manner in male germ cells through interaction with the LIM-only coactivator ACT (itself shuttled between nucleus and cytoplasm by the kinesin KIF17b in a PKA-dependent manner); the intronic ICER promoter, driven by CREB and repressed by ICER itself, creates a cAMP-inducible negative autoregulatory feedback loop controlling circadian, neuroendocrine, and hepatocyte proliferative responses; and in immune T cells, CaMKIV-mediated upregulation of CREMα drives epigenetic silencing of IL-2 and activation of IL-17A through HDAC1/DNMT3a recruitment and histone/DNA modifications at their promoters."},"narrative":{"mechanistic_narrative":"CREM is a modular bZip transcription factor of the CRE-binding family that generates a spectrum of activator and repressor isoforms through alternative splicing, alternative promoter usage, and alternative polyadenylation, thereby acting as a versatile regulator of cAMP-responsive transcription across germ cells, neuroendocrine tissue, heart, liver, and immune cells [PMID:1847666, PMID:1370576, PMID:8458330]. The earliest-defined isoforms are repressors that bind CRE sequences with the same specificity as CREB but down-regulate cAMP-induced transcription, and minimal bZip-only repressors compete with CREB/CREM for CRE and even TRE/AP-1 sites without requiring a phosphorylation domain [PMID:1847666, PMID:1429597, PMID:7809053]. In testis a developmental splicing switch produces the activator CREMtau, which carries glutamine-rich activation domains and is phosphorylated at Ser-117 by PKA to enhance transactivation, while p34cdc2 phosphorylation conversely suppresses its activation potential [PMID:1370576, PMID:8404858, PMID:8114763]; this switch is driven by FSH through alternative polyadenylation that stabilizes the transcript [PMID:7681549]. CREMtau can also be activated independently of Ser-117 phosphorylation by the LIM-only coactivator ACT, whose nuclear availability is controlled by the testis kinesin KIF17b under PKA regulation [PMID:10086359, PMID:12493914, PMID:16002395]. CREM is uniquely cAMP-inducible through an intronic promoter that drives the repressor ICER, which binds CREs in its own promoter to establish a negative autoregulatory feedback loop governing circadian melatonin synthesis in the pineal gland [PMID:8252624, PMID:8397338, PMID:8943074]. Genetically, CREM is essential for spermiogenesis—knockout males are sterile with postmeiotic arrest and loss of germ-cell genes including CYP51 and testicular ACE [PMID:8600390, PMID:8600391, PMID:10551787, PMID:9545342]—and is required for hepatocyte cell-cycle timing during liver regeneration and for normal cardiac contractile gene expression [PMID:9851970, PMID:12475904]. In T cells, CaMKIV/CaMK4-driven induction of CREMalpha represses IL-2 and activates IL-17A through recruitment of HDAC1 and DNMT3a and accompanying histone/DNA modifications, a pathway active in systemic lupus erythematosus and Th17 differentiation [PMID:15841182, PMID:22025620, PMID:21976679, PMID:24667640].","teleology":[{"year":1991,"claim":"Established that CREM is not merely a CREB paralog but a dedicated repressor of cAMP-induced transcription, defining a built-in antagonist within the CRE-binding system.","evidence":"PCR, RNase protection, cell-specific splicing analysis and transcription assays defining repressor isoforms with two alternative DNA-binding domains","pmids":["1847666"],"confidence":"High","gaps":["Did not explain how activator function could arise from the same gene","No in vivo physiological role yet defined"]},{"year":1992,"claim":"Showed the same gene can encode an activator (CREMtau) via alternative splicing of glutamine-rich domains and that a developmental antagonist-to-activator switch occurs during spermatogenesis, reframing CREM as a bifunctional regulator.","evidence":"Molecular cloning, functional transcription assays and developmental expression analysis in testis; plus DNA-binding competition showing repression of c-Jun/AP-1 by direct TRE binding","pmids":["1370576","1429597"],"confidence":"High","gaps":["Upstream signal triggering the developmental switch not identified","How activator activity is regulated post-translationally unresolved"]},{"year":1993,"claim":"Resolved how CREMtau activity is tuned, identifying PKA phosphorylation at Ser-117 as activating and p34cdc2 phosphorylation as inhibitory, and dissected the modular exon/domain architecture that mixes DNA-binding, phosphorylation, and activation modules across isoforms.","evidence":"In vitro/in vivo phosphorylation and site-directed mutagenesis, p34cdc2 coexpression, domain deletion analysis, heterodimerization and DNA-binding assays","pmids":["8404858","8458330","8114763","8102791","8290258"],"confidence":"High","gaps":["Phosphorylation-independent activation routes not yet known","Physiological kinases acting in vivo on each isoform incompletely mapped"]},{"year":1993,"claim":"Defined the FSH→CREM hormonal axis and the ICER autoregulatory loop, explaining how CREM becomes the only cAMP-inducible member of its family and how it self-limits via an intronic promoter.","evidence":"Hypophysectomy/hormone administration with polyadenylation and transcript-stability analysis (FSH); alternative intronic promoter cloning and ICER self-repression binding assays; circadian pineal expression analysis","pmids":["7681549","8252624","8397338"],"confidence":"High","gaps":["Direct target genes of CREMtau in germ cells not yet identified","Tissue range of the ICER loop not fully delineated"]},{"year":1993,"claim":"Connected CREMtau to specific postmeiotic gene activation, providing the first direct target evidence for the testis activator.","evidence":"EMSA, transfection reporters, and antibody-blocked in vitro transcription from the RT7 promoter using seminiferous tubule nuclear extracts","pmids":["8114765"],"confidence":"High","gaps":["Full set of postmeiotic targets unknown","In vivo requirement not yet tested genetically"]},{"year":1994,"claim":"Clarified heterodimer logic, showing CREMalpha contributes to PKA-dependent activation only when phosphorylatable, and identified a spermatid-specific bZip-only repressor isoform that competitively blocks CRE-driven transcription.","evidence":"Engineered leucine-zipper dimerization with PKA-dependent transcription readouts; RT-PCR, DNA-binding competition, reporter repression, and testis immunostaining","pmids":["7961842","7809053"],"confidence":"High","gaps":["Endogenous partner preferences in vivo not quantified","Spatial coordination of activator vs repressor isoforms within tubules unclear"]},{"year":1996,"claim":"Demonstrated CREM is essential for male fertility, establishing a definitive in vivo function: spermiogenesis arrests with postmeiotic apoptosis and loss of germ-cell genes in knockout males.","evidence":"Homologous-recombination knockout mice with histology, TUNEL apoptosis assays, and germ-cell gene expression analysis","pmids":["8600390","8600391"],"confidence":"High","gaps":["Molecular cause of apoptosis not fully resolved","Which isoforms drive the phenotype not separated genetically"]},{"year":1996,"claim":"Linked the ICER feedback loop to physiology, showing CREM/ICER governs circadian melatonin synthesis by repressing serotonin N-acetyltransferase, with photoperiod memory encoded by the CREB/ICER balance at the ICER promoter.","evidence":"CREM knockout mice, NAT promoter characterization, EMSA and reporter assays; photoperiod manipulation with promoter occupancy analysis","pmids":["8943074","8609995"],"confidence":"High","gaps":["Mechanism integrating prior photoperiod into promoter occupancy not molecularly resolved","Other circadian CREM/ICER targets not catalogued"]},{"year":1998,"claim":"Extended CREM function to somatic proliferation, showing it is induced during liver regeneration and required for proper hepatocyte cell-cycle timing after partial hepatectomy.","evidence":"Partial hepatectomy in knockout vs wild-type mice with BrdU incorporation, histomorphometry, and cyclin/cdc2 expression analysis","pmids":["9851970"],"confidence":"High","gaps":["Direct cell-cycle gene targets of CREM in hepatocytes not defined","Isoform responsible for proliferative role unidentified"]},{"year":1999,"claim":"Uncovered a phosphorylation-independent activation mechanism via the LIM-only coactivator ACT, explaining how CREMtau drives transcription in germ cells where PKA signaling may be limiting.","evidence":"Yeast two-hybrid screen, co-association and transcription assays in yeast and mammalian cells, phosphorylation-site mutant analysis","pmids":["10086359"],"confidence":"High","gaps":["How ACT availability is controlled was unknown at this point","Structural basis of ACT-CREM interaction not defined"]},{"year":2000,"claim":"Generalized ACT into the FHL family of CBP-independent LIM coactivators for CREB/CREM and mapped LIM-domain arrangements required for transactivation and CREM binding.","evidence":"Yeast and mammalian transcription assays, deletion analysis, and tissue expression profiling","pmids":["11046156"],"confidence":"Medium","gaps":["Single-lab functional data without structural validation","In vivo relevance of individual FHL proteins to CREM targets untested"]},{"year":2002,"claim":"Established that ACT nuclear availability—and hence CREM activation—is controlled by the testis kinesin KIF17b, whose CRM1-dependent nuclear export shuttles the coactivator.","evidence":"Reciprocal co-IP, immunofluorescence localization, leptomycin B perturbation, and stage-specific expression analysis","pmids":["12493914"],"confidence":"High","gaps":["Signal triggering stage-specific KIF17b interaction not yet defined","Quantitative contribution of shuttling to target gene output unmeasured"]},{"year":2002,"claim":"Identified concrete germ-cell CREM targets and a cell-type-specific regulatory takeover, showing CREMtau replaces SREBP-1 at CYP51 and is absolutely required for testicular ACE expression.","evidence":"CREM knockout analysis, EMSA with germ-cell nuclear extracts, promoter reporters, and transgenic CRE-mutation reporter for ACET","pmids":["10551787","9545342"],"confidence":"High","gaps":["Genome-wide germ-cell CREM target set still incomplete","Mechanism excluding SREBP-1 in germ cells not detailed"]},{"year":2002,"claim":"Revealed a cardiac role, showing CREM deficiency impairs contraction/relaxation with down-regulated beta1-adrenergic receptors and SERCA, identifying CREM as a regulator of cardiac gene expression.","evidence":"CREM knockout mice with hemodynamic assessment, beta-adrenergic stimulation, Western blot, and gene expression analysis","pmids":["12475904"],"confidence":"High","gaps":["Direct cardiac CRE target promoters not individually validated","Isoform balance underlying the phenotype unresolved"]},{"year":2003,"claim":"Refined the cardiac mechanism, attributing the depressed force-frequency relationship to CREM-dependent control of phospholamban phosphorylation via altered PP1 activity rather than gene expression changes.","evidence":"CREM knockout mice with pressure-volume loops, frequency protocols, Western blot, and PP1 activity assays","pmids":["12554693"],"confidence":"High","gaps":["How CREM controls PP1 activity mechanistically not defined","Transcriptional intermediary linking CREM to PP1 unidentified"]},{"year":2005,"claim":"Completed the germ-cell coactivator-trafficking circuit, showing PKA phosphorylation of KIF17b—through microtubule- and motor-independent transport—sets ACT nuclear availability and thus CREM activity.","evidence":"Domain-deletion mutants, microtubule depolymerization, in vitro PKA phosphorylation, and subcellular fractionation/localization","pmids":["16002395"],"confidence":"High","gaps":["Mechanism of motor-independent transport unexplained","In vivo phenotype of disrupting KIF17b phosphorylation untested"]},{"year":2005,"claim":"Opened the immune axis, demonstrating that nuclear CaMKIV drives CREM upregulation and enhanced IL-2 promoter binding to suppress IL-2 in SLE T cells, with TCR-reactive autoantibodies as the upstream trigger.","evidence":"Dominant-negative CaMKIV overexpression, CREM promoter binding (EMSA/ChIP), IL-2 reporter assays in SLE patient T cells","pmids":["15841182"],"confidence":"High","gaps":["Epigenetic mechanism of IL-2 silencing not yet defined at this stage","CREM isoform specificity in T cells not separated"]},{"year":2005,"claim":"Identified the splicing factor SRp40 as the controller of the CREM activator-to-repressor switch in pregnant myometrium, linking tissue physiology to isoform choice via exonic splicing enhancers.","evidence":"Splicing-factor transfection, in vitro splicing assays, SRp40 EMSA, and ESE mutagenesis","pmids":["16103121"],"confidence":"High","gaps":["Signals controlling SRp40 activity in pregnancy not defined","Functional consequence for myometrial gene programs untested"]},{"year":2006,"claim":"Added a chromatin dimension to CREM activator function, showing CREMtau heterodimerizes with Tisp40 to recruit the histone chaperone HIRA at CREs and to autoregulate Tisp40 transcription.","evidence":"Co-IP, EMSA, ChIP, and reporter assays demonstrating reciprocal binding and HIRA recruitment","pmids":["16595651"],"confidence":"High","gaps":["Functional outcome of HIRA recruitment on chromatin not assessed","Generality of Tisp40 partnership across tissues unknown"]},{"year":2011,"claim":"Defined the epigenetic mechanism of CREMalpha in T cells, showing it represses IL-2 via HDAC1/DNMT3a-mediated deacetylation and CpG hypermethylation while activating IL-17A through opposite epigenetic marks at its CRE.","evidence":"ChIP, bisulfite sequencing, siRNA knockdown, histone-modification and DNA-methylation analysis, and reporter assays in activated and SLE T cells","pmids":["21976679","22025620"],"confidence":"High","gaps":["How a single factor recruits opposing complexes at different loci unresolved","In vivo contribution to autoimmunity not directly tested here"]},{"year":2011,"claim":"Mapped a second autoregulatory loop in T cells, identifying the AP-1-driven intronic P2 promoter that drives activation-induced CREM and a reciprocal CREM repression of c-fos.","evidence":"EMSA, ChIP, reporter assays, and T-cell stimulation experiments","pmids":["21757709"],"confidence":"High","gaps":["Quantitative impact of P2 loop on CREM dosage in disease unclear","Interplay with the ICER loop not reconciled"]},{"year":2013,"claim":"Identified DAZAP1 as a splicing regulator promoting CREM exon 4 inclusion in testis, adding a germ-cell-specific layer to isoform control.","evidence":"Exon-usage microarrays, minigene splicing reporters, RNA-binding assays, and DAZAP1 knockout testis analysis","pmids":["23965306"],"confidence":"High","gaps":["Functional consequence of altered CREM splicing for spermatogenesis not isolated","Coordination with SRp40/other factors unknown"]},{"year":2014,"claim":"Placed CREMalpha as the effector of CaMK4 in Th17 differentiation, showing CaMK4 inhibition reduces IL-17A/F production via decreased CREMalpha activation.","evidence":"CaMK4 knockout mice, pharmacological inhibition, Th17 differentiation assays, cytokine/mRNA analysis, and siRNA in human SLE and healthy T cells","pmids":["24667640"],"confidence":"High","gaps":["Relative contribution of the AKT/mTOR arm vs CREMalpha not partitioned","In vivo therapeutic window not defined"]},{"year":2016,"claim":"Demonstrated that cardiac CREM repressor expression is arrhythmogenic, causing ion-channel remodeling and ventricular arrhythmia through suppression of CRE-dependent transcription.","evidence":"Transgenic CREM-IbDeltaC-X mice with patch clamp, calcium imaging, Western blot, RT-qPCR, and telemetry ECG","pmids":["26818679"],"confidence":"High","gaps":["Direct CRE targets driving NCX1/KChIP2 changes not pinpointed","Relevance to endogenous CREM isoform balance in disease unclear"]},{"year":2025,"claim":"Extended CREM into innate immune-effector regulation, showing it is induced via PKA-CREB downstream of CAR/IL-15 signaling and restrains CAR-NK effector function through epigenetic reprogramming, making CREM deletion a route to enhanced anti-tumor activity.","evidence":"Transcriptomics, CREM knockout, in vitro/in vivo tumor models, PKA-CREB pathway inhibition, and epigenetic profiling","pmids":["40468083"],"confidence":"High","gaps":["Specific CREM target loci in NK cells not enumerated","Isoform(s) responsible not resolved"]},{"year":null,"claim":"How the genome-wide repertoire of CREM activator and repressor isoforms is dynamically balanced within a single cell to produce locus-specific activation versus epigenetic silencing remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking isoform dosage to opposite epigenetic outcomes at different promoters","Structural basis for HDAC1/DNMT3a vs coactivator recruitment by the same factor undefined","Comprehensive in vivo target maps across tissues lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,5,9,26,29,30,34]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,5,11,13,21,22,28]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[11,18,20,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[9,11,20,28,29]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,3,9,29,30]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,26,33,35]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[28,29,30,35]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[26,29,30,33,35]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[6,27,32]}],"complexes":[],"partners":["CREB1","ACT/FHL5","KIF17B","TISP40","HDAC1","DNMT3A","HIRA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q03060","full_name":"cAMP-responsive element modulator","aliases":["Inducible cAMP early repressor","ICER"],"length_aa":345,"mass_kda":37.0,"function":"Transcriptional regulator that binds the cAMP response element (CRE), a sequence present in many viral and cellular promoters. Isoforms are either transcriptional activators or repressors. Plays a role in spermatogenesis and is involved in spermatid maturation (PubMed:10373550) May play a role in the regulation of the circadian clock: acts as a transcriptional repressor of the core circadian component PER1 by directly binding to cAMP response elements in its promoter","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q03060/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CREM","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CREM","total_profiled":1310},"omim":[{"mim_id":"614994","title":"CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE IG; CAMK1G","url":"https://www.omim.org/entry/614994"},{"mim_id":"612786","title":"CYCLIN Y; CCNY","url":"https://www.omim.org/entry/612786"},{"mim_id":"605571","title":"PIWI-LIKE RNA-MEDIATED GENE SILENCING 1; PIWIL1","url":"https://www.omim.org/entry/605571"},{"mim_id":"605521","title":"TATA BOX-BINDING PROTEIN-LIKE PROTEIN 1; TBPL1","url":"https://www.omim.org/entry/605521"},{"mim_id":"605126","title":"FOUR-AND-A-HALF LIM DOMAINS 5; FHL5","url":"https://www.omim.org/entry/605126"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"testis","ntpm":194.3}],"url":"https://www.proteinatlas.org/search/CREM"},"hgnc":{"alias_symbol":["hCREM-2"],"prev_symbol":[]},"alphafold":{"accession":"Q03060","domains":[{"cath_id":"1.20.5","chopping":"304-339","consensus_level":"medium","plddt":97.3142,"start":304,"end":339}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03060","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q03060-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q03060-F1-predicted_aligned_error_v6.png","plddt_mean":60.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CREM","jax_strain_url":"https://www.jax.org/strain/search?query=CREM"},"sequence":{"accession":"Q03060","fasta_url":"https://rest.uniprot.org/uniprotkb/Q03060.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q03060/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q03060"}},"corpus_meta":[{"pmid":"1847666","id":"PMC_1847666","title":"CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription.","date":"1991","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1847666","citation_count":619,"is_preprint":false},{"pmid":"8252624","id":"PMC_8252624","title":"Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8252624","citation_count":518,"is_preprint":false},{"pmid":"8600390","id":"PMC_8600390","title":"Spermiogenesis deficiency and germ-cell apoptosis in CREM-mutant mice.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8600390","citation_count":486,"is_preprint":false},{"pmid":"8600391","id":"PMC_8600391","title":"Severe impairment of spermatogenesis in mice lacking the CREM gene.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8600391","citation_count":454,"is_preprint":false},{"pmid":"1370576","id":"PMC_1370576","title":"Developmental switch of CREM function during spermatogenesis: from antagonist to activator.","date":"1992","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1370576","citation_count":444,"is_preprint":false},{"pmid":"8397338","id":"PMC_8397338","title":"Adrenergic signals direct rhythmic expression of transcriptional repressor CREM in the pineal gland.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8397338","citation_count":362,"is_preprint":false},{"pmid":"10390618","id":"PMC_10390618","title":"Signaling routes to CREM and CREB: plasticity in transcriptional activation.","date":"1999","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10390618","citation_count":241,"is_preprint":false},{"pmid":"7681549","id":"PMC_7681549","title":"Pituitary hormone FSH directs the CREM functional switch during spermatogenesis.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7681549","citation_count":236,"is_preprint":false},{"pmid":"8114765","id":"PMC_8114765","title":"Induction of CREM activator proteins in spermatids: down-stream targets and implications for haploid germ cell differentiation.","date":"1993","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8114765","citation_count":206,"is_preprint":false},{"pmid":"8458330","id":"PMC_8458330","title":"The functional versatility of CREM is determined by its modular structure.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8458330","citation_count":202,"is_preprint":false},{"pmid":"15841182","id":"PMC_15841182","title":"Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15841182","citation_count":191,"is_preprint":false},{"pmid":"10086359","id":"PMC_10086359","title":"CBP-independent activation of CREM and CREB by the LIM-only protein ACT.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10086359","citation_count":190,"is_preprint":false},{"pmid":"1429597","id":"PMC_1429597","title":"Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1429597","citation_count":188,"is_preprint":false},{"pmid":"24667640","id":"PMC_24667640","title":"CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24667640","citation_count":183,"is_preprint":false},{"pmid":"11046156","id":"PMC_11046156","title":"A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11046156","citation_count":181,"is_preprint":false},{"pmid":"8404858","id":"PMC_8404858","title":"Multiple and cooperative phosphorylation events regulate the CREM activator function.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8404858","citation_count":180,"is_preprint":false},{"pmid":"8102791","id":"PMC_8102791","title":"Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressors.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8102791","citation_count":153,"is_preprint":false},{"pmid":"11988318","id":"PMC_11988318","title":"The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis.","date":"2002","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11988318","citation_count":150,"is_preprint":false},{"pmid":"11969286","id":"PMC_11969286","title":"Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM.","date":"2002","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/11969286","citation_count":146,"is_preprint":false},{"pmid":"8943074","id":"PMC_8943074","title":"Transcriptional control of circadian hormone synthesis via the CREM feedback loop.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8943074","citation_count":130,"is_preprint":false},{"pmid":"7935450","id":"PMC_7935450","title":"A complex array of positive and negative elements regulates the chicken alpha A-crystallin gene: involvement of Pax-6, USF, CREB and/or CREM, and AP-1 proteins.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7935450","citation_count":129,"is_preprint":false},{"pmid":"22025620","id":"PMC_22025620","title":"cAMP-responsive element modulator (CREM)α protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22025620","citation_count":112,"is_preprint":false},{"pmid":"9247115","id":"PMC_9247115","title":"Cyclic AMP signalling and cellular proliferation: regulation of CREB and CREM.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9247115","citation_count":98,"is_preprint":false},{"pmid":"7651429","id":"PMC_7651429","title":"A Drosophila CREB/CREM homolog encodes multiple isoforms, including a cyclic AMP-dependent protein kinase-responsive transcriptional activator and antagonist.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7651429","citation_count":93,"is_preprint":false},{"pmid":"12493914","id":"PMC_12493914","title":"CREM-dependent transcription in male germ cells controlled by a kinesin.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12493914","citation_count":91,"is_preprint":false},{"pmid":"9510006","id":"PMC_9510006","title":"Testicular cAMP responsive element modulator (CREM) protein is expressed in round spermatids but is absent or reduced in men with round spermatid maturation arrest.","date":"1998","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/9510006","citation_count":88,"is_preprint":false},{"pmid":"10586058","id":"PMC_10586058","title":"The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10586058","citation_count":88,"is_preprint":false},{"pmid":"8386526","id":"PMC_8386526","title":"Transcriptional response to cAMP in brain: specific distribution and induction of CREM antagonists.","date":"1993","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/8386526","citation_count":87,"is_preprint":false},{"pmid":"8609995","id":"PMC_8609995","title":"Adaptive inducibility of CREM as transcriptional memory of circadian rhythms.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8609995","citation_count":82,"is_preprint":false},{"pmid":"31305268","id":"PMC_31305268","title":"Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion.","date":"2019","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31305268","citation_count":78,"is_preprint":false},{"pmid":"7809053","id":"PMC_7809053","title":"An isoform of transcription factor CREM expressed during spermatogenesis lacks the phosphorylation domain and represses cAMP-induced transcription.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7809053","citation_count":75,"is_preprint":false},{"pmid":"21976679","id":"PMC_21976679","title":"cAMP-responsive element modulator (CREM)α protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21976679","citation_count":73,"is_preprint":false},{"pmid":"10551787","id":"PMC_10551787","title":"Cyclic adenosine 3',5'-monophosphate(cAMP)/cAMP-responsive element modulator (CREM)-dependent regulation of cholesterogenic lanosterol 14alpha-demethylase (CYP51) in spermatids.","date":"1999","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/10551787","citation_count":69,"is_preprint":false},{"pmid":"18406739","id":"PMC_18406739","title":"Role of transcription factors CREB and CREM in cAMP-regulated transcription during spermatogenesis.","date":"1996","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/18406739","citation_count":68,"is_preprint":false},{"pmid":"9813195","id":"PMC_9813195","title":"CREM: a master-switch governing male germ cells differentiation and apoptosis.","date":"1998","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9813195","citation_count":66,"is_preprint":false},{"pmid":"9851970","id":"PMC_9851970","title":"Transcription factor CREM coordinates the timing of hepatocyte proliferation in the regenerating liver.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9851970","citation_count":58,"is_preprint":false},{"pmid":"17372992","id":"PMC_17372992","title":"ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17372992","citation_count":55,"is_preprint":false},{"pmid":"20920259","id":"PMC_20920259","title":"Cell-specific occupancy of an extended repertoire of CREM and CREB binding loci in male germ cells.","date":"2010","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/20920259","citation_count":54,"is_preprint":false},{"pmid":"11380701","id":"PMC_11380701","title":"cAMP response element modulator (CREM): an essential factor for spermatogenesis in primates?","date":"2001","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/11380701","citation_count":53,"is_preprint":false},{"pmid":"9129151","id":"PMC_9129151","title":"Cyclic AMP signalling pathway and cellular proliferation: induction of CREM during liver regeneration.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9129151","citation_count":52,"is_preprint":false},{"pmid":"7916662","id":"PMC_7916662","title":"Human CREM gene: evolutionary conservation, chromosomal localization, and inducibility of the transcript.","date":"1993","source":"Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/7916662","citation_count":46,"is_preprint":false},{"pmid":"16893891","id":"PMC_16893891","title":"Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16893891","citation_count":45,"is_preprint":false},{"pmid":"11079454","id":"PMC_11079454","title":"CREM, a master-switch of the transcriptional cascade in male germ cells.","date":"2000","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11079454","citation_count":43,"is_preprint":false},{"pmid":"16981198","id":"PMC_16981198","title":"Survival of DA neurons is independent of CREM upregulation in absence of CREB.","date":"2006","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/16981198","citation_count":42,"is_preprint":false},{"pmid":"33462743","id":"PMC_33462743","title":"Clear cell tumor with melanocytic differentiation and MITF-CREM translocation: a novel entity similar to clear cell sarcoma.","date":"2021","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33462743","citation_count":41,"is_preprint":false},{"pmid":"11420126","id":"PMC_11420126","title":"Transcriptional cascades during spermatogenesis: pivotal role of CREM and ACT.","date":"2001","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11420126","citation_count":39,"is_preprint":false},{"pmid":"15705296","id":"PMC_15705296","title":"Genetic control of spermiogenesis: insights from the CREM gene and implications for human infertility.","date":"2005","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/15705296","citation_count":38,"is_preprint":false},{"pmid":"24007532","id":"PMC_24007532","title":"Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24007532","citation_count":38,"is_preprint":false},{"pmid":"14754893","id":"PMC_14754893","title":"PE-1/METS, an antiproliferative Ets repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14754893","citation_count":38,"is_preprint":false},{"pmid":"40468083","id":"PMC_40468083","title":"CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.","date":"2025","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/40468083","citation_count":37,"is_preprint":false},{"pmid":"16002395","id":"PMC_16002395","title":"Microtubule-independent and protein kinase A-mediated function of kinesin KIF17b controls the intracellular transport of activator of CREM in testis (ACT).","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16002395","citation_count":36,"is_preprint":false},{"pmid":"8522985","id":"PMC_8522985","title":"Electroconvulsive seizure increases the expression of CREM (cyclic AMP response element modulator) and ICER (inducible cyclic AMP early repressor) in rat brain.","date":"1996","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8522985","citation_count":36,"is_preprint":false},{"pmid":"8735279","id":"PMC_8735279","title":"CREM: a master-switch in the transcriptional response to cAMP.","date":"1996","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/8735279","citation_count":35,"is_preprint":false},{"pmid":"10824972","id":"PMC_10824972","title":"CREM: a master-switch regulating the balance between differentiation and apoptosis in male germ cells.","date":"2000","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/10824972","citation_count":34,"is_preprint":false},{"pmid":"12475904","id":"PMC_12475904","title":"Impaired cardiac contraction and relaxation and decreased expression of sarcoplasmic Ca2+-ATPase in mice lacking the CREM gene.","date":"2002","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12475904","citation_count":33,"is_preprint":false},{"pmid":"7961842","id":"PMC_7961842","title":"Modulatory function of CREB.CREM alpha heterodimers depends upon CREM alpha phosphorylation.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7961842","citation_count":32,"is_preprint":false},{"pmid":"11044457","id":"PMC_11044457","title":"CREM activator and repressor isoforms in human testis: sequence variations and inaccurate splicing during impaired spermatogenesis.","date":"2000","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11044457","citation_count":32,"is_preprint":false},{"pmid":"10871295","id":"PMC_10871295","title":"Induction of cAMP response element modulator (CREM) and inducible cAMP early repressor (ICER) expression in rat brain by uncompetitive N-methyl-D-aspartate receptor antagonists.","date":"2000","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/10871295","citation_count":31,"is_preprint":false},{"pmid":"18775413","id":"PMC_18775413","title":"CREM modulates the circadian expression of CYP51, HMGCR and cholesterogenesis in the liver.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18775413","citation_count":29,"is_preprint":false},{"pmid":"21757709","id":"PMC_21757709","title":"A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21757709","citation_count":28,"is_preprint":false},{"pmid":"34228212","id":"PMC_34228212","title":"Intra-abdominal EWSR1/FUS-CREM-rearranged malignant epithelioid neoplasms: two cases of an emerging aggressive entity with emphasis on misleading immunophenotype.","date":"2021","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34228212","citation_count":28,"is_preprint":false},{"pmid":"10871653","id":"PMC_10871653","title":"Expression of the cyclic AMP-dependent transcription factors, CREB, CREM and ATF2, in the human myometrium during pregnancy and labour.","date":"2000","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/10871653","citation_count":28,"is_preprint":false},{"pmid":"19144833","id":"PMC_19144833","title":"The CREB/CREM transcription factors negatively regulate early synaptogenesis and spontaneous network activity.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19144833","citation_count":28,"is_preprint":false},{"pmid":"14742698","id":"PMC_14742698","title":"Expression of activator of CREM in the testis (ACT) during normal and impaired spermatogenesis: correlation with CREM expression.","date":"2004","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/14742698","citation_count":27,"is_preprint":false},{"pmid":"8290258","id":"PMC_8290258","title":"DNA bending by transcription factors CREM and CREB.","date":"1994","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8290258","citation_count":27,"is_preprint":false},{"pmid":"9159233","id":"PMC_9159233","title":"CREM: a transcriptional master switch during the spermatogenesis differentiation program.","date":"1996","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/9159233","citation_count":27,"is_preprint":false},{"pmid":"17275432","id":"PMC_17275432","title":"CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.","date":"2007","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/17275432","citation_count":27,"is_preprint":false},{"pmid":"8114763","id":"PMC_8114763","title":"Phosphorylation and negative regulation of the transcriptional activator CREM by p34cdc2.","date":"1993","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8114763","citation_count":26,"is_preprint":false},{"pmid":"11079452","id":"PMC_11079452","title":"The CREM system in human spermatogenesis.","date":"2000","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11079452","citation_count":25,"is_preprint":false},{"pmid":"8650267","id":"PMC_8650267","title":"The nuclear response to cAMP: role of transcription factor CREM.","date":"1996","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/8650267","citation_count":25,"is_preprint":false},{"pmid":"29925386","id":"PMC_29925386","title":"The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis.","date":"2018","source":"Pediatric rheumatology online journal","url":"https://pubmed.ncbi.nlm.nih.gov/29925386","citation_count":25,"is_preprint":false},{"pmid":"16595651","id":"PMC_16595651","title":"Transcription factors, cAMP-responsive element modulator (CREM) and Tisp40, act in concert in postmeiotic transcriptional regulation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16595651","citation_count":24,"is_preprint":false},{"pmid":"26818679","id":"PMC_26818679","title":"Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes.","date":"2016","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26818679","citation_count":23,"is_preprint":false},{"pmid":"34261344","id":"PMC_34261344","title":"Expression of Transcription Factor CREM in Human Tissues.","date":"2021","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/34261344","citation_count":22,"is_preprint":false},{"pmid":"15595950","id":"PMC_15595950","title":"Specialized rules of gene transcription in male germ cells: the CREM paradigm.","date":"2004","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/15595950","citation_count":22,"is_preprint":false},{"pmid":"34648001","id":"PMC_34648001","title":"Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice.","date":"2022","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/34648001","citation_count":22,"is_preprint":false},{"pmid":"22386572","id":"PMC_22386572","title":"Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.","date":"2012","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/22386572","citation_count":22,"is_preprint":false},{"pmid":"37057373","id":"PMC_37057373","title":"Clear cell tumor with melanocytic differentiation and MITF::CREM translocation.","date":"2023","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/37057373","citation_count":20,"is_preprint":false},{"pmid":"16048633","id":"PMC_16048633","title":"CREM activator and repressor isoform expression in human male germ cells.","date":"2005","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/16048633","citation_count":20,"is_preprint":false},{"pmid":"9846951","id":"PMC_9846951","title":"Regulating the balance between differentiation and apoptosis: role of CREM in the male germ cells.","date":"1998","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/9846951","citation_count":20,"is_preprint":false},{"pmid":"24166353","id":"PMC_24166353","title":"Upregulation of CREM-1 relates to retinal ganglion cells apoptosis after light-induced damage in vivo.","date":"2013","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/24166353","citation_count":20,"is_preprint":false},{"pmid":"12397208","id":"PMC_12397208","title":"Novel leader exons of the cyclic adenosine 3',5'-monophosphate response element modulator (CREM) gene, transcribed from promoters P3 and P4, are highly testis-specific in primates.","date":"2002","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12397208","citation_count":20,"is_preprint":false},{"pmid":"28368536","id":"PMC_28368536","title":"Transcription Factor CREM Mediates High Glucose Response in Cardiomyocytes and in a Male Mouse Model of Prolonged Hyperglycemia.","date":"2017","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28368536","citation_count":20,"is_preprint":false},{"pmid":"12554693","id":"PMC_12554693","title":"Novel regulation of cardiac force-frequency relation by CREM (cAMP response element modulator).","date":"2003","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12554693","citation_count":20,"is_preprint":false},{"pmid":"9545342","id":"PMC_9545342","title":"A cyclic AMP response element in the angiotensin-converting enzyme gene and the transcription factor CREM are required for transcription of the mRNA for the testicular isozyme.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9545342","citation_count":20,"is_preprint":false},{"pmid":"16103121","id":"PMC_16103121","title":"The switch in alternative splicing of cyclic AMP-response element modulator protein CREM{tau}2{alpha} (activator) to CREM{alpha} (repressor) in human myometrial cells is mediated by SRp40.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16103121","citation_count":19,"is_preprint":false},{"pmid":"23965306","id":"PMC_23965306","title":"DAZAP1 regulates the splicing of Crem, Crisp2 and Pot1a transcripts.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23965306","citation_count":19,"is_preprint":false},{"pmid":"33616852","id":"PMC_33616852","title":"Clear Cell Odontogenic Carcinoma: First Report of Novel EWSR1-CREM Fusion Gene in Case of Long-Term Misdiagnosis.","date":"2021","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33616852","citation_count":19,"is_preprint":false},{"pmid":"16687568","id":"PMC_16687568","title":"Sequencing and haplotype analysis of the activator of CREM in the testis (ACT) gene in populations of fertile and infertile males.","date":"2006","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/16687568","citation_count":19,"is_preprint":false},{"pmid":"39249507","id":"PMC_39249507","title":"Extra-abdominal and intra-abdominal FET::CREM fusion mesenchymal neoplasms: comparative clinicopathological study of 9 new cases further supporting a distinct potentially aggressive sarcoma and report of novel sites.","date":"2024","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/39249507","citation_count":18,"is_preprint":false},{"pmid":"37628737","id":"PMC_37628737","title":"Novel Aspects of cAMP-Response Element Modulator (CREM) Role in Spermatogenesis and Male Fertility.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37628737","citation_count":18,"is_preprint":false},{"pmid":"25381014","id":"PMC_25381014","title":"Upregulation of CREM/ICER suppresses wound endothelial CRE-HIF-1α-VEGF-dependent signaling and impairs angiogenesis in type 2 diabetes.","date":"2014","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/25381014","citation_count":18,"is_preprint":false},{"pmid":"18786638","id":"PMC_18786638","title":"Regulation of neural migration by the CREB/CREM transcription factors and altered Dab1 levels in CREB/CREM mutants.","date":"2008","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/18786638","citation_count":18,"is_preprint":false},{"pmid":"32668333","id":"PMC_32668333","title":"Primary Intracranial Mesenchymal Tumor with EWSR1-CREM Gene Fusion: A Case Report and Literature Review.","date":"2020","source":"World neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/32668333","citation_count":17,"is_preprint":false},{"pmid":"28439100","id":"PMC_28439100","title":"Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability.","date":"2017","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28439100","citation_count":17,"is_preprint":false},{"pmid":"28973639","id":"PMC_28973639","title":"1,2-Dichloroethane Induces Reproductive Toxicity Mediated by the CREM/CREB Signaling Pathway in Male NIH Swiss Mice.","date":"2017","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/28973639","citation_count":17,"is_preprint":false},{"pmid":"26459392","id":"PMC_26459392","title":"The cAMP response element modulator (CREM) regulates TH2 mediated inflammation.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26459392","citation_count":17,"is_preprint":false},{"pmid":"7642572","id":"PMC_7642572","title":"The cyclic AMP response elements of the genes for angiotensin converting enzyme and phosphoenolpyruvate carboxykinase (GTP) can mediate transcriptional activation by CREM tau and CREM alpha.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7642572","citation_count":17,"is_preprint":false},{"pmid":"12555239","id":"PMC_12555239","title":"Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12555239","citation_count":17,"is_preprint":false},{"pmid":"11327716","id":"PMC_11327716","title":"Cloning and expression of activator of CREM in testis in human testicular tissue.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11327716","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45766,"output_tokens":8767,"usd":0.134402,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18762,"output_tokens":7487,"usd":0.140492,"stage2_stop_reason":"end_turn"},"total_usd":0.274894,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"CREM encodes multiple isoforms (repressors) generated by alternative cell-specific splicing that use two alternative DNA-binding domains; CREM proteins bind CRE sequences with the same efficiency and specificity as CREB but act as down-regulators (antagonists) of cAMP-induced transcription.\",\n      \"method\": \"PCR, RNase protection, cell-specific splicing analysis, transcription assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — original characterization using multiple orthogonal methods (PCR, RNase protection, in vitro binding, transcription assays); replicated extensively by subsequent independent studies\",\n      \"pmids\": [\"1847666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"A novel CREM isoform (CREM tau) expressed in adult testis contains two glutamine-rich activation domains inserted by alternative splicing and functions as a transcriptional activator rather than a repressor; during spermatogenesis, CREM undergoes a developmental switch from antagonist isoforms in premeiotic cells to the CREM tau activator from pachytene spermatocytes onwards.\",\n      \"method\": \"Alternative splicing analysis, functional transcription assays, developmental expression analysis in testis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (molecular cloning, transcription assays, developmental stage analysis); independently replicated by multiple labs\",\n      \"pmids\": [\"1370576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CREM antagonists repress c-Jun-mediated transcriptional activation not by heterodimerizing with Fos/Jun proteins, but by directly binding to TRE (AP-1) sequences and competing with c-Jun for these sites; removal of the phosphorylation domain from CREM does not affect this down-regulatory function.\",\n      \"method\": \"Transcription assays, DNA-binding competition, dimerization analysis, domain deletion mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — mechanistic dissection using domain deletion mutants and direct binding competition assays in a single rigorous study with multiple orthogonal approaches\",\n      \"pmids\": [\"1429597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CREM is uniquely inducible within the CRE-binding family upon cAMP pathway activation; an alternative intronic promoter drives expression of a novel repressor isoform ICER (inducible cAMP early repressor); ICER binds to four CREs in its own intronic promoter and represses its own transcription, establishing a negative autoregulatory feedback loop.\",\n      \"method\": \"Alternative promoter cloning, kinetic induction analysis, protein synthesis inhibition, transfection reporter assays, ICER binding assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (promoter characterization, reporter assays, binding assays, cycloheximide experiments); replicated by multiple independent studies\",\n      \"pmids\": [\"8252624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CREM tau activator is phosphorylated at serine-117 by endogenous germ cell protein kinase A; this phosphorylation enhances transcriptional activation. Casein kinase I and II cooperatively phosphorylate CREM tau on multiple residues to enhance DNA binding. Multiple signal transduction pathways (cAMP, TPA, Ca2+ ionophore) converge on phosphorylation of Ser-117.\",\n      \"method\": \"In vitro and in vivo phosphorylation assays, site-directed mutagenesis, DNA-binding assays, transactivation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro kinase assays with multiple kinases, in vivo phosphorylation, and functional transcription assays; multiple orthogonal methods in single study\",\n      \"pmids\": [\"8404858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The CREM gene has a modular exon structure; isoforms are generated by exon shuffling producing proteins with various combinations of functional domains. CREM isoforms heterodimerize in vivo with each other and with CREB; the two alternative DNA-binding domains show distinct binding efficiencies (CREM alpha/CREB heterodimers bind consensus CRE more strongly than CREM beta/CREB heterodimers). The phosphorylation domain and a single glutamine-rich domain are sufficient for activation. A minimal CREM repressor containing only the bZip motif efficiently antagonizes cAMP-induced transcription. A Ser phosphoacceptor site mutation (CREM beta S68) increases repressor function.\",\n      \"method\": \"Exon structure determination, in vivo heterodimerization, in vitro DNA binding assays, domain deletion/mutation analysis, transcription assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — comprehensive domain analysis with multiple deletion and point mutants, in vivo and in vitro assays, multiple orthogonal methods\",\n      \"pmids\": [\"8458330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"FSH is responsible for directing the CREM developmental switch from antagonist to activator (CREM tau) in testis; FSH regulates CREM expression by alternative polyadenylation, which results in dramatic enhancement of transcript stability. Hypophysectomy abolishes CREM tau expression, and FSH administration restores it.\",\n      \"method\": \"Hypophysectomy, hormone administration, polyadenylation analysis, transcript stability measurement\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo hormonal manipulation with multiple controls, molecular mechanism (alternative polyadenylation/stability) demonstrated; replicated in independent systems\",\n      \"pmids\": [\"7681549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The KID (kinase-inducible domain) of CREB/CREM-alpha acts as a conditional activator that can confer cAMP-inducible transcriptional activation even to activation domains on a separate polypeptide bound at an adjacent promoter site, suggesting KID functions as a trans-acting conditional activator module.\",\n      \"method\": \"Domain fusion/swap transcription assays, artificial tethering experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transcription assays with domain fusions; single lab, primarily focused on CREB mechanism with CREM-alpha as comparator\",\n      \"pmids\": [\"8102791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CREM tau activator is phosphorylated by p34cdc2 on multiple serine and threonine residues in vitro and in vivo; p34cdc2-mediated phosphorylation does not affect CREM tau DNA binding but strongly reduces its trans-activation potential (as shown by coexpression of constitutively active p34cdc2 mutant).\",\n      \"method\": \"In vitro and in vivo phosphorylation assays, constitutively active p34cdc2 coexpression, transactivation assays, DNA binding assays\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstituted phosphorylation plus in vivo validation with active mutant and functional readout; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"8114763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CREM tau binds to CREs in the promoters of several postmeiotic germ cell-specific genes (including RT7); CREM tau activates the RT7 promoter in transfection assays; CREM-specific antibodies block in vitro transcription from the RT7 promoter using seminiferous tubule nuclear extracts, directly implicating CREM tau in activating postmeiotic gene expression.\",\n      \"method\": \"EMSA, transient transfection reporter assays, in vitro transcription with antibody blockade, nuclear extracts from seminiferous tubules\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro transcription assay with antibody inhibition plus transfection assays; multiple orthogonal methods in single study\",\n      \"pmids\": [\"8114765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Rhythmic adrenergic signals from the circadian clock drive ICER expression in the pineal gland via the cAMP signal transduction pathway; ICER levels show striking circadian fluctuation (peak at night), correlating inversely with melatonin synthesis.\",\n      \"method\": \"In vivo circadian expression analysis, adrenergic stimulation, cAMP pathway activation\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo physiological system with pharmacological pathway manipulation; independently confirmed by multiple subsequent studies\",\n      \"pmids\": [\"8397338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"An alternatively spliced CREM isoform (CREM delta C-G) lacking the PKA phosphorylation domain and glutamine-rich activation domains retains the bZip DNA-binding domain, competitively inhibits CREB/CREM binding to CREs, represses CRE-driven reporter transcription, and is expressed in elongated spermatids in rat testis.\",\n      \"method\": \"RT-PCR, DNA binding competition, reporter gene repression assays, immunostaining of testis sections\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (molecular, cellular, tissue); competitive binding and functional repression demonstrated\",\n      \"pmids\": [\"7809053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CREM alpha can contribute to PKA-mediated gene activation when selectively heterodimerized with CREB (using engineered leucine zipper specificity), and this transcriptional activity depends on the ability of the complexes to be phosphorylated by PKA; non-phosphorylated CREB.CREM alpha heterodimers are non-functional.\",\n      \"method\": \"Engineered leucine zipper dimerization, in vivo transcription assays, PKA phosphorylation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — engineered dimerization specificity with functional readout; mechanistic dissection of heterodimer activity vs. phosphorylation state\",\n      \"pmids\": [\"7961842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CREM and CREB proteins induce bending in DNA sequences flanking the CRE recognition site; phosphorylation of CREM or CREB enhances the angle of DNA bending induced by these proteins, while not affecting binding affinity differences between the two alternative DNA-binding domains of CREM.\",\n      \"method\": \"Permutated binding site gel retardation assay (circular permutation), bacterially expressed proteins\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with purified protein but single lab, single method\",\n      \"pmids\": [\"8290258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Homozygous CREM-mutant male mice (generated by homologous recombination) are sterile; spermatogenesis arrests at the first step of spermiogenesis with complete absence of late spermatids, a 10-fold increase in apoptotic germ cells, and lack of postmeiotic cell-specific gene expression. Female mice are fertile, confirming a male germ cell-specific essential function.\",\n      \"method\": \"Homologous recombination knockout, histology, TUNEL/apoptosis assays, gene expression analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent knockout studies published simultaneously with comprehensive phenotypic and molecular characterization\",\n      \"pmids\": [\"8600390\", \"8600391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CREM-deficient mice show dramatically elevated serotonin N-acetyltransferase (NAT) expression in the pineal gland; the NAT promoter contains an ICER binding site; ICER powerfully represses NAT transcription in transfection assays; thus CREM/ICER acts as a central regulator of circadian melatonin synthesis.\",\n      \"method\": \"CREM knockout mice, promoter characterization, EMSA, transfection reporter assays\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function genetics combined with promoter binding and functional reporter assays; multiple orthogonal methods\",\n      \"pmids\": [\"8943074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The transcriptional response of the CREM gene to adrenergic stimulation is determined by the memory of past photoperiods (night length); differential responsiveness is controlled by the changing balance between positive (CREB) and negative (ICER) transcriptional regulators occupying the ICER promoter.\",\n      \"method\": \"Photoperiod manipulation in vivo, adrenergic stimulation, CREM/ICER expression quantification, promoter occupancy analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo physiological system with mechanistic promoter occupancy data; single lab but multiple conditions and orthogonal measurements\",\n      \"pmids\": [\"8609995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CREM gene expression is robustly induced during liver regeneration after partial hepatectomy; CREM-deficient mice show significantly reduced hepatocyte proliferation (reduced DNA synthesis, fewer mitoses, delayed S-phase entry, deregulated cyclin/cdc2 expression), demonstrating CREM is required for normal timing of the hepatocyte cell cycle after partial hepatectomy.\",\n      \"method\": \"Partial hepatectomy in CREM knockout vs. wild-type mice, BrdU incorporation, histomorphometry, gene expression analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with defined proliferative phenotype and molecular characterization; single lab but multiple orthogonal readouts\",\n      \"pmids\": [\"9851970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ACT (activator of CREM in testis), a LIM-only protein, specifically associates with CREM in male germ cells (isolated by yeast two-hybrid, confirmed by co-association); ACT has intrinsic transcriptional activation function and strongly stimulates CREM transcriptional activity independent of Ser-117 phosphorylation and CBP interaction, establishing a phosphorylation-independent route for CREM activation.\",\n      \"method\": \"Yeast two-hybrid screen, co-association assays, transcriptional activation assays in yeast and mammalian cells, phosphorylation-independent mutant analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid discovery with in vivo functional validation in multiple cell systems; mechanism confirmed by phosphorylation-site mutants; replicated by multiple subsequent studies\",\n      \"pmids\": [\"10086359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"A family of FHL (four-and-a-half-LIM-domain) proteins share structural organization with ACT and provide CBP-independent transcriptional activation to both CREB and CREM in tissue-specific and developmentally regulated manner; specific ACT LIM domain arrangements are essential for both transactivation and interaction with CREM.\",\n      \"method\": \"Yeast and mammalian cell transcription assays, deletion analysis, tissue expression profiling\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transcription assays with domain deletions in multiple cell systems; single lab\",\n      \"pmids\": [\"11046156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ACT selectively associates with testis-specific kinesin KIF17b; the ACT-KIF17b interaction is restricted to specific stages of spermatogenesis and directly determines the intracellular localization of ACT; KIF17b can be actively exported from the nucleus through the CRM1 receptor (leptomycin B-sensitive), thereby controlling CREM-dependent transcription in male germ cells through regulation of coactivator localization.\",\n      \"method\": \"Co-immunoprecipitation, subcellular localization (immunofluorescence), leptomycin B treatment, stage-specific expression analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, live-cell localization with pharmacological perturbation, and stage-specific analysis; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"12493914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CREM-null mice lack abundant germ cell-specific CYP51 mRNA transcripts in testis (while somatic CYP51 remains unaffected); CREMtau binds to a conserved CRE2 element in the CYP51 promoter in germ cell nuclear extracts, whereas SREBP-1 (the somatic regulator) does not bind in germ cells; thus CREMtau-dependent regulation of CYP51 is the dominant pathway in haploid germ cells, replacing the SREBP-dependent cholesterogenic regulation.\",\n      \"method\": \"CREM knockout analysis, EMSA with germ cell nuclear extracts, promoter reporter assays\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic loss-of-function combined with biochemical promoter-binding analysis demonstrating cell-type-specific regulatory mechanism\",\n      \"pmids\": [\"10551787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CREM is required for postmeiotic transcription of ACE testicular isozyme (ACET): ACET mRNA is absent from testes of CREM-null mice while pulmonary ACE remains unaffected; a CRE element 5' of the ACET transcription start site is absolutely essential for testicular expression (shown by transgenic reporter).\",\n      \"method\": \"CREM knockout mice, transgenic reporter analysis, CRE mutation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function combined with transgenic CRE mutation establishing direct requirement for CREM at a specific promoter element\",\n      \"pmids\": [\"9545342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CREM deficiency results in impaired cardiac contraction and relaxation, selective down-regulation of beta1-adrenergic receptors, and decreased ventricular SERCA (Ca2+-ATPase) expression; CREM-null mice show decreased responsiveness to beta-adrenergic stimulation, establishing CREM as a key regulator of cardiac gene expression required for normal contractile performance.\",\n      \"method\": \"CREM knockout mice, left ventricular hemodynamic assessment, beta-adrenergic stimulation, Western blot, gene expression analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with multiple molecular and functional cardiac phenotype readouts; single lab\",\n      \"pmids\": [\"12475904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CREM-null mice display markedly depressed cardiac force-frequency relationship (contractile augmentation and relaxation at faster rates); this is associated with reduced total and serine-phosphorylated phospholamban protein and increased protein phosphatase-1 (PP1) activity in CREM-/- hearts, without changes in SERCA or phospholamban gene expression or beta-adrenergic signaling, demonstrating novel CREM-dependent regulation of PP1 and PLB post-translational modification.\",\n      \"method\": \"CREM knockout mice, in vivo pressure-volume loops, frequency-dependent protocols, Western blot, PP1 activity assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with mechanistic protein-level analysis; multiple orthogonal readouts; single lab\",\n      \"pmids\": [\"12554693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"KIF17b transport of ACT is microtubule-independent and motor domain-independent; protein kinase A phosphorylates KIF17b, and this phosphorylation determines KIF17b's subcellular localization, thereby controlling CREM-mediated transcription in male germ cells through regulation of ACT nuclear availability.\",\n      \"method\": \"Domain deletion mutants, microtubule depolymerization assays, in vitro phosphorylation by PKA, subcellular fractionation/localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro phosphorylation combined with domain deletion and subcellular localization experiments; mechanistic pathway clearly established\",\n      \"pmids\": [\"16002395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CaMKIV is increased in the nucleus of SLE T cells and is responsible for increased CREM expression and enhanced CREM binding to the IL-2 promoter (-180 CRE site), leading to decreased IL-2 production; expression of a dominant-inactive CaMKIV abolishes SLE-serum-induced CREM upregulation; anti-TCR/CD3 autoantibodies in SLE IgG are responsible for CaMKIV activation.\",\n      \"method\": \"Dominant-negative CaMKIV overexpression, CREM promoter binding assays (EMSA/ChIP), IL-2 promoter reporter assays, SLE patient T cells\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative genetic approach combined with binding and reporter assays; establishes CaMKIV→CREM→IL-2 pathway in patient cells\",\n      \"pmids\": [\"15841182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The splicing factor SRp40 mediates the switch in CREM alternative splicing in human myometrial cells from CREMtau2alpha (activator) to CREMalpha (repressor) during pregnancy; SRp40 acts through multiple ESE (exonic splicing enhancer) motifs in the alternatively spliced CREM exons.\",\n      \"method\": \"Transient transfection of splicing factors, in vitro splicing assays, EMSA with SRp40, ESE mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro splicing reconstitution and in vivo functional assays with ESE mutations; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"16103121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CREMtau and Tisp40 (a bZip transcription factor) form a heterodimer that binds CRE motifs (but not UPRE); Tisp40 dramatically enhances CREM binding to CRE; the Tisp40DeltaTM-CREMtau heterodimer recruits histone chaperone HIRA to CRE sites; CREM regulates Tisp40alpha transcription, and both proteins co-occupy the Tisp40 promoter in vivo (ChIP).\",\n      \"method\": \"Co-immunoprecipitation, EMSA, ChIP, reporter assays, in vivo binding\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal interactions demonstrated by multiple methods (Co-IP, EMSA, ChIP); functional consequence (HIRA recruitment) characterized\",\n      \"pmids\": [\"16595651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CREMα physically binds to a CRE site at -111/-104 within the proximal human IL17A promoter and increases its transcriptional activity; CREMα binding correlates with epigenetic changes (H3K27 hypomethylation, H3K18 hyperacetylation, CpG hypomethylation) at the IL17A locus in activated T cells and SLE T cells; decreased HDAC1 and DNMT3a recruitment to this CRE site accounts for the epigenetic alterations.\",\n      \"method\": \"ChIP, reporter assays, DNA methylation analysis, histone modification analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-confirmed promoter binding, reporter assays with mutation, and epigenetic characterization; multiple orthogonal methods; single lab\",\n      \"pmids\": [\"22025620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CREMα mediates silencing of the IL2 gene in SLE T lymphocytes through recruitment of HDAC1 leading to gene-wide H3K18 deacetylation and DNMT3a-mediated CpG-DNA hypermethylation at the IL2 gene locus.\",\n      \"method\": \"ChIP, bisulfite sequencing (CpG methylation), siRNA knockdown, reporter assays with methylated promoter\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-based epigenetic mechanism with multiple modifications measured; functional reporter validation; single lab\",\n      \"pmids\": [\"21976679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A novel intronic CREM promoter (P2) upstream of exon 2 is regulated by AP-1 transcription factors; T cell activation via CD3/CD28 or PMA/ionomycin enhances P2 promoter activity; in SLE T cells, decreased c-Fos (an AP-1 component) impairs activation-induced CREM upregulation through P2; CREM trans-represses c-fos transcription in SLE T cells, establishing a CREM-AP-1 autoregulatory feedback loop.\",\n      \"method\": \"DNA binding studies (EMSA), ChIP, reporter assays, T cell stimulation experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA, ChIP, and reporter assays establishing AP-1-dependent promoter regulation and feedback mechanism; multiple orthogonal methods\",\n      \"pmids\": [\"21757709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DAZAP1 promotes inclusion of CREM exon 4 in splicing reporter transcripts; DAZAP1 binds to regulatory regions in CREM intron 3 and regulates exon inclusion; DAZAP1-deficient mouse testes show aberrant CREM splicing, identifying DAZAP1 as a splicing regulator of CREM.\",\n      \"method\": \"Microarray exon usage analysis, minigene splicing reporters, RNA-binding assays, DAZAP1 knockout\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo splicing changes in knockout mice combined with minigene and binding studies; multiple orthogonal methods\",\n      \"pmids\": [\"23965306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CaMK4 is required for Th17 cell differentiation; CaMK4 activates CREMα which in turn increases IL17A and IL17F transcription; CaMK4 also activates the AKT/mTOR pathway. Genetic or pharmacological inhibition of CaMK4 reduces IL-17 production through decreased CREMα activation; silencing CaMK4 in SLE and healthy T cells inhibits Th17 differentiation via reduction of IL17A and IL17F mRNA.\",\n      \"method\": \"CaMK4 knockout mice, pharmacological inhibition, Th17 differentiation assays, cytokine measurement, mRNA analysis, siRNA in human T cells\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (KO mice) and pharmacological inhibition with molecular readouts; validated in human SLE patient T cells; multiple independent approaches\",\n      \"pmids\": [\"24667640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Transgenic cardiac expression of CREM repressor isoform CREM-IbΔC-X leads to arrhythmogenic alterations in ventricular cardiomyocytes including enhanced NCX-mediated Ca2+ transport, increased NCX1 protein, decreased Ito and KChIP2 subunit, action potential prolongation, early afterdepolarizations, and ventricular extrasystoles in vivo; CREM repressor expression suppresses CRE-dependent transcription to produce an arrhythmogenic remodeling substrate.\",\n      \"method\": \"Transgenic mouse model, patch clamp, calcium imaging, Western blot, RT-qPCR, telemetry ECG\",\n      \"journal\": \"Basic research in cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic gain-of-function with comprehensive electrophysiological, molecular, and in vivo functional analysis; multiple orthogonal methods\",\n      \"pmids\": [\"26818679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CREM is induced in CAR-NK cells by both CAR activation and IL-15 signaling via the PKA-CREB signaling pathway downstream of ITAM/CAR signaling; CREM deletion enhances CAR-NK cell effector function in vitro and in vivo and increases resistance to tumor-induced immunosuppression; CREM exerts its regulatory functions through epigenetic reprogramming of CAR-NK cells.\",\n      \"method\": \"Transcriptomic analysis, CREM knockout, in vitro and in vivo functional assays, pharmacological PKA-CREB pathway inhibition, epigenetic profiling\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function combined with in vivo tumor models, pathway epistasis, and epigenetic characterization; multiple orthogonal methods in peer-reviewed Nature paper\",\n      \"pmids\": [\"40468083\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CREM is a modular bZip transcription factor that generates multiple activator and repressor isoforms through alternative splicing, alternative promoter usage, and alternative polyadenylation; repressor isoforms compete with CREB for CRE binding while the activator isoform CREMτ is phosphorylated at Ser-117 by PKA (and regulated negatively by p34cdc2) or activated in a phosphorylation-independent manner in male germ cells through interaction with the LIM-only coactivator ACT (itself shuttled between nucleus and cytoplasm by the kinesin KIF17b in a PKA-dependent manner); the intronic ICER promoter, driven by CREB and repressed by ICER itself, creates a cAMP-inducible negative autoregulatory feedback loop controlling circadian, neuroendocrine, and hepatocyte proliferative responses; and in immune T cells, CaMKIV-mediated upregulation of CREMα drives epigenetic silencing of IL-2 and activation of IL-17A through HDAC1/DNMT3a recruitment and histone/DNA modifications at their promoters.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CREM is a modular bZip transcription factor of the CRE-binding family that generates a spectrum of activator and repressor isoforms through alternative splicing, alternative promoter usage, and alternative polyadenylation, thereby acting as a versatile regulator of cAMP-responsive transcription across germ cells, neuroendocrine tissue, heart, liver, and immune cells [#0, #1, #5]. The earliest-defined isoforms are repressors that bind CRE sequences with the same specificity as CREB but down-regulate cAMP-induced transcription, and minimal bZip-only repressors compete with CREB/CREM for CRE and even TRE/AP-1 sites without requiring a phosphorylation domain [#0, #2, #11]. In testis a developmental splicing switch produces the activator CREMtau, which carries glutamine-rich activation domains and is phosphorylated at Ser-117 by PKA to enhance transactivation, while p34cdc2 phosphorylation conversely suppresses its activation potential [#1, #4, #8]; this switch is driven by FSH through alternative polyadenylation that stabilizes the transcript [#6]. CREMtau can also be activated independently of Ser-117 phosphorylation by the LIM-only coactivator ACT, whose nuclear availability is controlled by the testis kinesin KIF17b under PKA regulation [#18, #20, #25]. CREM is uniquely cAMP-inducible through an intronic promoter that drives the repressor ICER, which binds CREs in its own promoter to establish a negative autoregulatory feedback loop governing circadian melatonin synthesis in the pineal gland [#3, #10, #15]. Genetically, CREM is essential for spermiogenesis—knockout males are sterile with postmeiotic arrest and loss of germ-cell genes including CYP51 and testicular ACE [#14, #21, #22]—and is required for hepatocyte cell-cycle timing during liver regeneration and for normal cardiac contractile gene expression [#17, #23]. In T cells, CaMKIV/CaMK4-driven induction of CREMalpha represses IL-2 and activates IL-17A through recruitment of HDAC1 and DNMT3a and accompanying histone/DNA modifications, a pathway active in systemic lupus erythematosus and Th17 differentiation [#26, #29, #30, #33].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established that CREM is not merely a CREB paralog but a dedicated repressor of cAMP-induced transcription, defining a built-in antagonist within the CRE-binding system.\",\n      \"evidence\": \"PCR, RNase protection, cell-specific splicing analysis and transcription assays defining repressor isoforms with two alternative DNA-binding domains\",\n      \"pmids\": [\"1847666\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not explain how activator function could arise from the same gene\", \"No in vivo physiological role yet defined\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Showed the same gene can encode an activator (CREMtau) via alternative splicing of glutamine-rich domains and that a developmental antagonist-to-activator switch occurs during spermatogenesis, reframing CREM as a bifunctional regulator.\",\n      \"evidence\": \"Molecular cloning, functional transcription assays and developmental expression analysis in testis; plus DNA-binding competition showing repression of c-Jun/AP-1 by direct TRE binding\",\n      \"pmids\": [\"1370576\", \"1429597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal triggering the developmental switch not identified\", \"How activator activity is regulated post-translationally unresolved\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Resolved how CREMtau activity is tuned, identifying PKA phosphorylation at Ser-117 as activating and p34cdc2 phosphorylation as inhibitory, and dissected the modular exon/domain architecture that mixes DNA-binding, phosphorylation, and activation modules across isoforms.\",\n      \"evidence\": \"In vitro/in vivo phosphorylation and site-directed mutagenesis, p34cdc2 coexpression, domain deletion analysis, heterodimerization and DNA-binding assays\",\n      \"pmids\": [\"8404858\", \"8458330\", \"8114763\", \"8102791\", \"8290258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation-independent activation routes not yet known\", \"Physiological kinases acting in vivo on each isoform incompletely mapped\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defined the FSH→CREM hormonal axis and the ICER autoregulatory loop, explaining how CREM becomes the only cAMP-inducible member of its family and how it self-limits via an intronic promoter.\",\n      \"evidence\": \"Hypophysectomy/hormone administration with polyadenylation and transcript-stability analysis (FSH); alternative intronic promoter cloning and ICER self-repression binding assays; circadian pineal expression analysis\",\n      \"pmids\": [\"7681549\", \"8252624\", \"8397338\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes of CREMtau in germ cells not yet identified\", \"Tissue range of the ICER loop not fully delineated\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Connected CREMtau to specific postmeiotic gene activation, providing the first direct target evidence for the testis activator.\",\n      \"evidence\": \"EMSA, transfection reporters, and antibody-blocked in vitro transcription from the RT7 promoter using seminiferous tubule nuclear extracts\",\n      \"pmids\": [\"8114765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of postmeiotic targets unknown\", \"In vivo requirement not yet tested genetically\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Clarified heterodimer logic, showing CREMalpha contributes to PKA-dependent activation only when phosphorylatable, and identified a spermatid-specific bZip-only repressor isoform that competitively blocks CRE-driven transcription.\",\n      \"evidence\": \"Engineered leucine-zipper dimerization with PKA-dependent transcription readouts; RT-PCR, DNA-binding competition, reporter repression, and testis immunostaining\",\n      \"pmids\": [\"7961842\", \"7809053\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous partner preferences in vivo not quantified\", \"Spatial coordination of activator vs repressor isoforms within tubules unclear\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Demonstrated CREM is essential for male fertility, establishing a definitive in vivo function: spermiogenesis arrests with postmeiotic apoptosis and loss of germ-cell genes in knockout males.\",\n      \"evidence\": \"Homologous-recombination knockout mice with histology, TUNEL apoptosis assays, and germ-cell gene expression analysis\",\n      \"pmids\": [\"8600390\", \"8600391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular cause of apoptosis not fully resolved\", \"Which isoforms drive the phenotype not separated genetically\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Linked the ICER feedback loop to physiology, showing CREM/ICER governs circadian melatonin synthesis by repressing serotonin N-acetyltransferase, with photoperiod memory encoded by the CREB/ICER balance at the ICER promoter.\",\n      \"evidence\": \"CREM knockout mice, NAT promoter characterization, EMSA and reporter assays; photoperiod manipulation with promoter occupancy analysis\",\n      \"pmids\": [\"8943074\", \"8609995\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism integrating prior photoperiod into promoter occupancy not molecularly resolved\", \"Other circadian CREM/ICER targets not catalogued\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Extended CREM function to somatic proliferation, showing it is induced during liver regeneration and required for proper hepatocyte cell-cycle timing after partial hepatectomy.\",\n      \"evidence\": \"Partial hepatectomy in knockout vs wild-type mice with BrdU incorporation, histomorphometry, and cyclin/cdc2 expression analysis\",\n      \"pmids\": [\"9851970\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cell-cycle gene targets of CREM in hepatocytes not defined\", \"Isoform responsible for proliferative role unidentified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Uncovered a phosphorylation-independent activation mechanism via the LIM-only coactivator ACT, explaining how CREMtau drives transcription in germ cells where PKA signaling may be limiting.\",\n      \"evidence\": \"Yeast two-hybrid screen, co-association and transcription assays in yeast and mammalian cells, phosphorylation-site mutant analysis\",\n      \"pmids\": [\"10086359\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ACT availability is controlled was unknown at this point\", \"Structural basis of ACT-CREM interaction not defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Generalized ACT into the FHL family of CBP-independent LIM coactivators for CREB/CREM and mapped LIM-domain arrangements required for transactivation and CREM binding.\",\n      \"evidence\": \"Yeast and mammalian transcription assays, deletion analysis, and tissue expression profiling\",\n      \"pmids\": [\"11046156\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab functional data without structural validation\", \"In vivo relevance of individual FHL proteins to CREM targets untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Established that ACT nuclear availability—and hence CREM activation—is controlled by the testis kinesin KIF17b, whose CRM1-dependent nuclear export shuttles the coactivator.\",\n      \"evidence\": \"Reciprocal co-IP, immunofluorescence localization, leptomycin B perturbation, and stage-specific expression analysis\",\n      \"pmids\": [\"12493914\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal triggering stage-specific KIF17b interaction not yet defined\", \"Quantitative contribution of shuttling to target gene output unmeasured\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified concrete germ-cell CREM targets and a cell-type-specific regulatory takeover, showing CREMtau replaces SREBP-1 at CYP51 and is absolutely required for testicular ACE expression.\",\n      \"evidence\": \"CREM knockout analysis, EMSA with germ-cell nuclear extracts, promoter reporters, and transgenic CRE-mutation reporter for ACET\",\n      \"pmids\": [\"10551787\", \"9545342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide germ-cell CREM target set still incomplete\", \"Mechanism excluding SREBP-1 in germ cells not detailed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Revealed a cardiac role, showing CREM deficiency impairs contraction/relaxation with down-regulated beta1-adrenergic receptors and SERCA, identifying CREM as a regulator of cardiac gene expression.\",\n      \"evidence\": \"CREM knockout mice with hemodynamic assessment, beta-adrenergic stimulation, Western blot, and gene expression analysis\",\n      \"pmids\": [\"12475904\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cardiac CRE target promoters not individually validated\", \"Isoform balance underlying the phenotype unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Refined the cardiac mechanism, attributing the depressed force-frequency relationship to CREM-dependent control of phospholamban phosphorylation via altered PP1 activity rather than gene expression changes.\",\n      \"evidence\": \"CREM knockout mice with pressure-volume loops, frequency protocols, Western blot, and PP1 activity assays\",\n      \"pmids\": [\"12554693\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CREM controls PP1 activity mechanistically not defined\", \"Transcriptional intermediary linking CREM to PP1 unidentified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Completed the germ-cell coactivator-trafficking circuit, showing PKA phosphorylation of KIF17b—through microtubule- and motor-independent transport—sets ACT nuclear availability and thus CREM activity.\",\n      \"evidence\": \"Domain-deletion mutants, microtubule depolymerization, in vitro PKA phosphorylation, and subcellular fractionation/localization\",\n      \"pmids\": [\"16002395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of motor-independent transport unexplained\", \"In vivo phenotype of disrupting KIF17b phosphorylation untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Opened the immune axis, demonstrating that nuclear CaMKIV drives CREM upregulation and enhanced IL-2 promoter binding to suppress IL-2 in SLE T cells, with TCR-reactive autoantibodies as the upstream trigger.\",\n      \"evidence\": \"Dominant-negative CaMKIV overexpression, CREM promoter binding (EMSA/ChIP), IL-2 reporter assays in SLE patient T cells\",\n      \"pmids\": [\"15841182\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Epigenetic mechanism of IL-2 silencing not yet defined at this stage\", \"CREM isoform specificity in T cells not separated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified the splicing factor SRp40 as the controller of the CREM activator-to-repressor switch in pregnant myometrium, linking tissue physiology to isoform choice via exonic splicing enhancers.\",\n      \"evidence\": \"Splicing-factor transfection, in vitro splicing assays, SRp40 EMSA, and ESE mutagenesis\",\n      \"pmids\": [\"16103121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals controlling SRp40 activity in pregnancy not defined\", \"Functional consequence for myometrial gene programs untested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Added a chromatin dimension to CREM activator function, showing CREMtau heterodimerizes with Tisp40 to recruit the histone chaperone HIRA at CREs and to autoregulate Tisp40 transcription.\",\n      \"evidence\": \"Co-IP, EMSA, ChIP, and reporter assays demonstrating reciprocal binding and HIRA recruitment\",\n      \"pmids\": [\"16595651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional outcome of HIRA recruitment on chromatin not assessed\", \"Generality of Tisp40 partnership across tissues unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the epigenetic mechanism of CREMalpha in T cells, showing it represses IL-2 via HDAC1/DNMT3a-mediated deacetylation and CpG hypermethylation while activating IL-17A through opposite epigenetic marks at its CRE.\",\n      \"evidence\": \"ChIP, bisulfite sequencing, siRNA knockdown, histone-modification and DNA-methylation analysis, and reporter assays in activated and SLE T cells\",\n      \"pmids\": [\"21976679\", \"22025620\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single factor recruits opposing complexes at different loci unresolved\", \"In vivo contribution to autoimmunity not directly tested here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapped a second autoregulatory loop in T cells, identifying the AP-1-driven intronic P2 promoter that drives activation-induced CREM and a reciprocal CREM repression of c-fos.\",\n      \"evidence\": \"EMSA, ChIP, reporter assays, and T-cell stimulation experiments\",\n      \"pmids\": [\"21757709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative impact of P2 loop on CREM dosage in disease unclear\", \"Interplay with the ICER loop not reconciled\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified DAZAP1 as a splicing regulator promoting CREM exon 4 inclusion in testis, adding a germ-cell-specific layer to isoform control.\",\n      \"evidence\": \"Exon-usage microarrays, minigene splicing reporters, RNA-binding assays, and DAZAP1 knockout testis analysis\",\n      \"pmids\": [\"23965306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of altered CREM splicing for spermatogenesis not isolated\", \"Coordination with SRp40/other factors unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Placed CREMalpha as the effector of CaMK4 in Th17 differentiation, showing CaMK4 inhibition reduces IL-17A/F production via decreased CREMalpha activation.\",\n      \"evidence\": \"CaMK4 knockout mice, pharmacological inhibition, Th17 differentiation assays, cytokine/mRNA analysis, and siRNA in human SLE and healthy T cells\",\n      \"pmids\": [\"24667640\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of the AKT/mTOR arm vs CREMalpha not partitioned\", \"In vivo therapeutic window not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated that cardiac CREM repressor expression is arrhythmogenic, causing ion-channel remodeling and ventricular arrhythmia through suppression of CRE-dependent transcription.\",\n      \"evidence\": \"Transgenic CREM-IbDeltaC-X mice with patch clamp, calcium imaging, Western blot, RT-qPCR, and telemetry ECG\",\n      \"pmids\": [\"26818679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct CRE targets driving NCX1/KChIP2 changes not pinpointed\", \"Relevance to endogenous CREM isoform balance in disease unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended CREM into innate immune-effector regulation, showing it is induced via PKA-CREB downstream of CAR/IL-15 signaling and restrains CAR-NK effector function through epigenetic reprogramming, making CREM deletion a route to enhanced anti-tumor activity.\",\n      \"evidence\": \"Transcriptomics, CREM knockout, in vitro/in vivo tumor models, PKA-CREB pathway inhibition, and epigenetic profiling\",\n      \"pmids\": [\"40468083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific CREM target loci in NK cells not enumerated\", \"Isoform(s) responsible not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the genome-wide repertoire of CREM activator and repressor isoforms is dynamically balanced within a single cell to produce locus-specific activation versus epigenetic silencing remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking isoform dosage to opposite epigenetic outcomes at different promoters\", \"Structural basis for HDAC1/DNMT3a vs coactivator recruitment by the same factor undefined\", \"Comprehensive in vivo target maps across tissues lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 5, 9, 26, 29, 30, 34]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 5, 11, 13, 21, 22, 28]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [11, 18, 20, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [9, 11, 20, 28, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 3, 9, 29, 30]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 26, 33, 35]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [28, 29, 30, 35]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [26, 29, 30, 33, 35]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [6, 27, 32]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CREB1\", \"ACT/FHL5\", \"KIF17b\", \"Tisp40\", \"HDAC1\", \"DNMT3a\", \"HIRA\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}